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SEPSIS 2015:  
YOU SAY YOU WANT A REVOLUTION 
POTENTIAL CONFLICTS OF INTEREST 
• Hold leadership position in Surviving Sepsis 
Campaign 
 
• Cooper University Hospital receives consultant 
fees and research funding from Spectral Inc. for 

















• Severe Sepsis is the Leading Cause of Hospital 
Death 
• Admissions with severe sepsis 8X > chance of death 
than other conditions 
• Most expensive condition treated in the hospital 
(23 billion dollars per annum) 
• Enormous economic burden that can be lessened 
with early identification and early appropriate 
evidence based medicine care 
NCHS data brief #62, 2011 
US National Lib Med, NIH, 2010 
HCUP Statistical Brief #160 
Causes of death in New Jersey in 2011, according to the most recent data available.  
New Jersey Department of Health posted January 8, 2015 

“HEALTHCARE, WE HAVE A PROBLEM.” 

CURRENTLY FUNDED WITH A GORDON 
AND BETTY MOORE FOUNDATION 
GRANT 
(INTEL FAMILY).  
 
NO DIRECT OR INDIRECT INDUSTRY 
SUPPORT FOR GUIDELINES REVISION 
 R. Phillip Dellinger, Mitchell M. Levy, Andrew Rhodes, Djillali Annane, 
Herwig Gerlach, Steven M. Opal, Jonathan E. Sevransky, Charles L. 
Sprung, Ivor S. Douglas, Roman Jaeschke, Tiffany M. Osborn, Mark E. 
Nunnally, Sean R. Townsend, Konrad Reinhart, Ruth M. Kleinpell, Derek 
C. Angus, Clifford S. Deutschman, Flavia R. Machado,Gordon D. 
Rubenfeld, Steven A. Webb, Richard J. Beale, Jean-Louis Vincent, Rui 
Moreno, and the Surviving Sepsis Campaign Guidelines Committee 
including the Pediatric Subgroup.  
Crit Care Med 2013; 41:580-637  
Intensive Care Medicine 2013; 39: 165-228 
 
SURVIVING SEPSIS CAMPAIGN: INTERNATIONAL 
GUIDELINES FOR MANAGEMENT OF SEVERE SEPSIS 
AND SEPTIC SHOCK: 2012 
CURRENT SURVIVING SEPSIS CAMPAIGN GUIDELINE 
SPONSORS  
• American Association of Critical-Care Nurses 
• American College of Chest Physicians 
• American College of Emergency Physicians 
• Australian and New Zealand Intensive Care 
Society 
• Asia Pacific Association of Critical Care 
Medicine 
• American Thoracic Society 
• Brazilian Society of Critical Care(AIMB) 
• Canadian Critical Care Society 
• Chinese Society of Critical Care Medicine 
• Emirates Intensive Care Society  
• European Respiratory Society 
• European Society of Clinical Microbiology 
and Infectious Diseases 
• European Society of Intensive Care Medicine 
• European Society of Pediatric and Neonatal 
Intensive Care 




• Indian Society of Critical Care Medicine 
• International Pan Arab Critical Care Medicine 
Society 
• Japanese Association for Acute Medicine 
• Japanese Society of Intensive Care Medicine 
• Pediatric Acute Lung Injury and Sepsis 
Investigators 
• Society Academic Emergency Medicine 
• Society of Critical Care Medicine 
• Society of Hospital Medicine 
• Surgical Infection Society 
• World Federation of Critical Care Nurses 
• World Federation of Pediatric Intensive and 
Critical Care Societies  
• World Federation of Societies of Intensive and 
Critical Care Medicine 
Participation and endorsement: 
German Sepsis Society 
Latin American Sepsis Institute 
 
GUIDELINES ARE NOT ENOUGH 
• Protocols 
• Performance Improvement Programs 
• Audit and Feedback 
Early Screening and a Hospital Based Performance 
Improvement Program 
GUIDELINES TO BUNDLES 





CHANGE IN COMPLIANCE OVER TIME 
Levy  MM, Dellinger, RP, Townsend SA et al.   
CCM 38(2):367-374, February 2010. 
CHANGE IN MORTALITY OVER TIME 
Levy  MM, Dellinger, RP, Townsend SA et al.   
CCM 38(2):367-374, February 2010. 
Levy, et al. Crit Care Med. 2015 Jan;43(1):3-12. 
SSC MORTALITY 
Levy, et al. Crit Care Med. 2015 Jan;43(1):3-12. 
                  WHY? 
Levy, et al. Crit Care Med. 2015 Jan;43(1):3-12. 
INITIAL RESUSCITATION OF SEPSIS INDUCED TISSUE 
HYPOPERFUSION 
Recommend  
Insertion central venous catheter 
Recommended goals : 
• Central venous pressure: 8–12 mm Hg 
• Higher with altered ventricular compliance or 
increased intrathoracic pressure  
• ScvO2 saturation (SVC)  70% 
Grade 1C 
STARLING PRINCIPLE RELATES TO 
VOLUME 
The Starling 
principle relates to 
the fact that the 
more a myocardial 
fibril is stretched 
the greater the 
contraction. 
EXPECTED RESULT OF VOLUME 
EXPANSION 
CENTRAL VENOUS PRESSURE POORLY 
PREDICTS CARDIAC PRELOAD AND 
VOLUME STATUS 
Michard F, et al. Chest 2002; 121:2000–2008. 
 Kumar A, et al. Crit Care Med 2004; 32:691–699. 
Shippy CR, et al. Crit Care Med 1984; 12:107–112. 
INTRAVASCULAR VOLUME STATUS AND 
PERFUSION PARAMETERS  
 
•  Limitation of pressure measurement 
to predict fluid responsiveness 
 
•  There are alternatives to CVP for 
judging fluid responsiveness that are 
in general more reliable 
 
 
ARTERIAL SYSTOLIC PRESSURE 
VARIATION 
Parry-Jones, et al. Int J Respir Crit Care Med 2003;2:67 




EFFECT ON STROKE VOLUME 
EFFECT ON STROKE VOLUME 

Revolution 
You say you want a revolution  
NATIONAL QUALITY FORUM 
2012 NQF: SEPSIS 0500 
TO BE COMPLETED WITHIN 3 HOURS OF TIME OF 
PRESENTATION  : 
 
1. Measure lactate level 
2. Obtain blood cultures prior to administration of antibiotics 
3. Administer broad spectrum antibiotics 





2012 NQF: SEPSIS 0500  
 
TO BE COMPLETED WITHIN 6 HOURS OF TIME OF 
PRESENTATION: 
 
5. Apply vasopressors (for hypotension that does not 
respond to initial fluid resuscitation to maintain a mean 
arterial pressure (MAP) ≥65mmHg) 
6. In the event of persistent arterial hypotension despite 
volume resuscitation (septic shock) or initial lactate ≥4 
mmol/L (36mg/dl): 
        - Measure central venous pressure (CVP)       
        - Measure central venous oxygen saturation 
(ScvO2) 




N Engl J Med. 2014 May 1;370(18):1683-93. 
 
N Engl J Med. 2014 Oct 16;371(16):1496-506. 
 
1600 Patients 
Over 1500 Patients 
Both the ProCESS and ARISE trials 
demonstrated the lack of necessity of 
using central venous oxygen saturation 
and central venous pressure monitoring 
as resuscitation targets when compared 
to the usual care group.  





You say you got a real solution 
Well, you know 
We’d all love to see the plan 
You ask me for a contribution 
Well, you know 
We’re all doing what we can 
Revolution 
Revolution 
You tell me it’s (for) the institution  
N Engl J Med. 2014 May 1;370(18):1683-93. 
 
N Engl J Med. 2014 Oct 16;371(16):1496-506. 
 
1600 Patients 
Over 1500 Patients 
ProCESS ARISE 
Enrollment <2 hours from 
detection of shock 
2.8 hours (median) 
from presentation to 
ED 
Antibiotics 75% received prior 
to enrollment 
70 minutes (median) 
from presentation to 
ED 
Fluids >2 liters prior ot 
enrollment  
2515ml (mean) prior 
to enrollment  
• SSC 2006 six hour bundle 
• SSC 2012 three hour bundle 
• NQF 0500 
• ProCESS/ARISE/PROMISE 
• NQF 0500 (revised) 
• CMS SEP 1 
TO SAVE LIVES..... 
Early fluid resuscitation  
Early antibiotics 
Early identification  

IMPORTANCE OF REASSESSMENT 
• Sepsis is a big problem 
• Logic of indicators is good 
• Benchmarked performance 
 
 
CMS SEP-1  
 
Revolution 
Don’t you know it’s gonna be 
alright, alright, alright 
 
 
Research / New or 
Ongoing Clinical 
Trials 
            SELEPRESSIN 
Koshimizu, et al. Physiol Rev. 2012 Oct;92(4):1813-64. 
V1A Receptor  
 

                LB1148 
Gut Integrity in Shock 
“SSAIL” TRIAL (TREATMENT OF SEPTIC SHOCK BY 
INHIBITING AUTODIGESTION AND PRESERVING 
GUT INTEGRITY WITH ENTERIC LB1148) 
• LB1148 – broad-spectrum serine 
protease inhibitor delivered enterally 
to gut 
 
• Inhibit the intraluminal pancreatic 
proteolytic enzymes (proteases) that 
leak due to loss of gut integrity 
        SOLUBLE THROMBOMODULIN 


            ANGIOTENSIN II 

Chawla, et al. Crit Care. 2014 Oct 6;18(5):534. 
        POLYMYXIN B HEMOPERFUSION 
Endotoxemia 
SOURCES OF ENDOTOXIN 
Endotoxin translocation  
from GI Tract 
 Every human has 25-30 grams  
of Endotoxin in their GI tract 
 Less than 0.001 grams of Endotoxin  
is enough to kill a person 
Endotoxin shed from local 
bacterial infection 
Opal SM, et al. Infect Dis, 1999 
SEPSIS AND ENDOTOXIN 
INTERVENTION  
DIRECT HEMOPERFUSION WITH ADSORBENT COLUMN USING                                 
POLYMYXIN B IMMOBILIZED FIBER 
ANTICOAGULANT 
Heparin (3000 U in bolus followed by a 
continuous infusion of 20 U/kg/h)  
FEMORAL  or IJ VEIN 




Perfusion rate 80-120 ml/min 
Duration: 2 hours 
HEMODYNAMIC EFFECTS OF PMX 




ENDOTOXIN ACTIVITY ASSAY 
 EAA™ 
The only FDA cleared test for detection of Endotoxin 
Thank 
You 
